GeneDx Holdings Corp. · Healthcare · Diagnostics & Research
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$79.50
−$1.88 (−2.31%) 4:00 PM ET
After hours$80.00
+$0.50 (+0.63%) 4:41 AM ET
Prev closePrevC$81.38
OpenOpen$79.40
Day highHigh$80.31
Day lowLow$76.49
VolumeVol770,758
Avg volAvgVol785,808
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$2.30B
P/E ratio
-106.00
FY Revenue
$427.54M
EPS
-0.75
Gross Margin
69.74%
Sector
Healthcare
AI report sections
MIXED
WGS
GeneDx Holdings Corp.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+18% (Above avg)
Vol/Avg: 1.18×
RSI
34.77(Weak)
Weak (30–40)
0255075100
MACD momentum
Intraday
-0.00 (Weak)
MACD: 0.16 Signal: 0.17
Short-Term
+0.43 (Strong)
MACD: -7.75 Signal: -8.18
Long-Term
+0.33 (Strong)
MACD: -17.08 Signal: -17.41
Intraday trend score
61.00
LOW28.70HIGH61.00
Latest news
WGS•12 articles•Positive: 1Neutral: 1Negative: 10
PositiveThe Motley Fool• Sarah Sidlow
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump
GeneDX CEO Katherine Stueland sold 2,158 shares on October 29, 2025, primarily to cover tax obligations after converting restricted stock units. The transaction was part of routine accounting and does not indicate a loss of confidence in the company.
WGSWGSWWgenetic testingAIhealthcare technologyinsider tradingstock sale
Sentiment note
The company has seen an 84% stock price increase in one year, is leveraging AI in genomic testing, and operates in a growing healthcare technology market with strong future potential
NegativeBenzinga• Benzinga Staff Writer
10 Health Care Stocks With Whale Alerts In Today's Session
Multiple health care stocks experienced significant options trading activity, with various bullish and bearish signals across different companies in the sector.
Bearish call option sweep with high-value contracts
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Accused of fraudulent schemes to artificially inflate revenue through exploitation of Medicaid and Medicare systems, resulting in stock price decline and potential legal action
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Accused of fraudulent schemes targeting Medicaid and Medicare systems, with stock price falling after fraud allegations, indicating significant reputational and financial risk
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Accused of fraudulent schemes to artificially inflate revenue through exploitation of Medicaid and Medicare systems, resulting in stock price decline and potential legal action
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Accused of fraudulent schemes to artificially inflate revenue through exploitation of Medicaid and Medicare systems, resulting in stock price decline and potential legal action
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleging fraudulent business practices, which caused the stock to drop 6.7%.
Grizzly Research report accused the company of widespread fraud, deliberately exploiting Medicaid and Medicare systems to artificially inflate revenue, leading to a significant stock price decline
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
Law firm investigating potential securities law violations by GeneDx after a research report alleged fraudulent business practices, including illegal billing and revenue inflation.
Grizzly Research report accused the company of widespread fraud, illegal billing practices, code stacking, and suspicious insider stock selling, causing a 6.72% stock price drop
NegativeGlobeNewswire Inc.• Brandon Walker
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm
Law firm Bragar Eagel & Squire is investigating potential securities law violations for four companies, focusing on financial performance issues and alleged fraudulent practices that negatively impacted investor value.
Accused of widespread fraud by Grizzly Research, including allegations of revenue inflation and illegal billing practices, leading to a 6.72% stock price decline
NeutralGlobeNewswire Inc.• Rosen Law Firm
VRA Investor News: If You Have Suffered Losses in Vera Bradley, Inc. (NASDAQ: VRA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims for Vera Bradley shareholders after the company reported disappointing first quarter financial results, causing a 19% stock price drop.
Limited information provided in the article excerpt
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleging fraudulent business practices, which caused the stock to drop 6.7%.
Accused of widespread fraud, deliberately exploiting Medicaid and Medicare systems to artificially inflate revenue, resulting in stock price decline and potential legal action
NegativeGlobeNewswire Inc.• Rosen Law Firm
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Accused of fraudulent schemes to artificially inflate revenue through illegal Medicare and Medicaid exploitation, resulting in stock price decline and potential legal action
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal